1-(3-Chlorophenyl)-2,2,2-trifluoroethylamine, 95.0%, 100mg

2-[2-oxo-2-(2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl)ethyl]-1H-isoindole-1,3(2H)-dione, 95.0%, 25mg

Methyl 2-ethyl-3-hydroxybenzoate, 95.0%, 250mg

Sodium 2-methyl-2-(pyrazin-2-yl)propanoate, 95.0%, 250mg

4'-Chloroacetophenone>97.0%(GC)500g

4-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)benzoic acid, 95.0%, 10g

2,3-Difluoro-5-(methoxycarbonyl)phenylboronic acid, 97%, 1g

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,25 µm, 1 Stück

2-(4-Isopropoxy-3-methoxyphenyl)acetic acid, 98%, 250mg

Bis(2-((S)-4-phenyl-4,5-dihydrooxazol-2-yl)phenyl)amine, 97%, 1g

(S)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid hydrobromide, 95.0%, 250mg

(1r)-1-(1-Benzofuran-2-yl)ethan-1-ol, 95%, 250mg

N-(3-(Aminomethyl)pyridin-2-yl)-N-methylmethanesulfonamide acetate, 97.0%, 250mg